Chronic Liver Disease. Liver disease, unspecified
Conditions
Interventions
Intervention 1: Training was conducted in 6 sessions. In the first two sessions, which were the subject of meetings liver disease, and its impact on nutrition. 4 other meeting issues of energy consump
Training was conducted in 6 sessions. In the first two sessions, which were the subject of meetings liver disease, and its impact on nutrition. 4 other meeting issues of energy consumption, carbohydra
Training was conducted over 2 sessions. Which were the subject of meetings liver disease, and its impact on nutrition
Sponsors
Department of Science and Technology of Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 18 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria for children: 1. Children with liver disease who are at least 6 months old disease 2. Iranian citizenship is a lie Mashhad. 3. patients tend to have the company study. 4. phone calls possible. 5. Children with chronic liver disease have other physical limitations. 6. children with chronic liver disease, mental health is not restricted. 7. aged 2 to 18 years old. Exclusion criteria related to children: 1. there is no desire to continue cooperation. 2. children to be fed TPN. 3. Children need to have a feeding tube. Inclusion criteria for the appropriate care: 1. The desire to have the company study. 2. Help is at least the third degree. 3 phone calls possible. Exclusion criteria for the appropriate care: 1. Randashth workshop is willing to continue cooperating companies
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: First and end of the study. Method of measurement: Questionnaire Peds ql 4.0.;Prothrombin time. Timepoint: First and end of the study. Method of measurement: Values obtained from tests of Biochemistry.;Albumin. Timepoint: First and end of the study. Method of measurement: Values obtained from tests of Biochemistry.;Bilirubin. Timepoint: First and end of the study. Method of measurement: Values obtained from tests of Biochemistry.;Aspartate aminotransferase. Timepoint: First and end of the study. Method of measurement: Values obtained from tests of blood.;Alanine amino transferase. Timepoint: First and end of the study. Method of measurement: Values obtained from tests of blood. | — |
Secondary
| Measure | Time frame |
|---|---|
| Height. Timepoint: First and end of the study. Method of measurement: The value of the stadiometer.;Weight. Timepoint: First and end of the study. Method of measurement: The value of the bio-electrical impedance devices.;Body Mass Index. Timepoint: First and end of the study. Method of measurement: Body weight divided by the square of Height is achieved Index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactzahra namjou
Mashhad University of Medical Sciences
Outcome results
None listed